A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

Clinical trial NCT05113745 · COMPLETED

Trial details

NCT number: NCT05113745
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Narcolepsy Cataplexy Excessive Daytime Sleepiness

Start date: 2021-10-20
Primary completion: 2024-11-15
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.